Table 5.
Groups | ALT |
AST |
AST/ALT ratio |
---|---|---|---|
U/L | |||
Normal groups | |||
Negative control | 29.33 ± 1.02 | 25.83 ± 1.11 | 0.88 ± 0.21 |
Extract control group | 29 ± 1.71 | 26.31 ± 1.31 | 0.91 ± 0.13 |
Ehrlich Ascites carcinoma bearing mice | |||
Tumor bearing mice | 110 ± 0.05** | 450 ± 2.14** | 4.09 ± 1.32** |
FU treated group | 90 ± 1.51* | 192 ± 1.05* | 1.92 ± 0.31* |
% change | −18.18% | −57.33% | −53.06% |
Extract treated group | 77.9 ± 0.199* | 180.5 ± 0.437* | 2.194 ± 0.95* |
% change | −29.18% | −59.88% | −46.45% |
Data are presented as mean of five animals ± SD. One-way ANOVA was used for data analysis followed by post Hoc for multiple comparisons (n = 5, p < 0.05). Bearing mice and + ve controls were compared to –ve control group (**) while treated groups were compared to bearing group (*). FU; flouro uracil treated group, ALT; Glutamic- pyruvic transaminase, AST; Glutamic- oxaloacetic transaminase.